427 related articles for article (PubMed ID: 26842851)
1. Utility of FDG-PET/CT in the diagnosis of IgG4-related diseases.
Zhao Z; Wang Y; Guan Z; Jin J; Huang F; Zhu J
Clin Exp Rheumatol; 2016; 34(1):119-25. PubMed ID: 26842851
[TBL] [Abstract][Full Text] [Related]
2. The utility of FDG-PET/CT and other imaging techniques in the evaluation of IgG4-related disease.
Takahashi H; Yamashita H; Morooka M; Kubota K; Takahashi Y; Kaneko H; Kano T; Mimori A
Joint Bone Spine; 2014 Jul; 81(4):331-6. PubMed ID: 24568886
[TBL] [Abstract][Full Text] [Related]
3. Utility of FDG PET/CT for Differential Diagnosis of Patients Clinically Suspected of IgG4-Related Disease.
Lee J; Hyun SH; Kim S; Kim DK; Lee JK; Moon SH; Cho YS; Choe YS; Kim BT; Lee KH
Clin Nucl Med; 2016 May; 41(5):e237-43. PubMed ID: 26914555
[TBL] [Abstract][Full Text] [Related]
4. Characterizing IgG4-related disease with ¹⁸F-FDG PET/CT: a prospective cohort study.
Zhang J; Chen H; Ma Y; Xiao Y; Niu N; Lin W; Wang X; Liang Z; Zhang F; Li F; Zhang W; Zhu Z
Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1624-34. PubMed ID: 24764034
[TBL] [Abstract][Full Text] [Related]
5. Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease.
Berti A; Della-Torre E; Gallivanone F; Canevari C; Milani R; Lanzillotta M; Campochiaro C; Ramirez GA; Bozzalla Cassione E; Bozzolo E; Pedica F; Castiglioni I; Arcidiacono PG; Balzano G; Falconi M; Gianolli L; Dagna L
Rheumatology (Oxford); 2017 Dec; 56(12):2084-2092. PubMed ID: 28977663
[TBL] [Abstract][Full Text] [Related]
6. Total lesion glycolysis as an IgG4-related disease activity marker.
Nakatsuka Y; Handa T; Nakamoto Y; Nobashi T; Yoshihuji H; Tanizawa K; Ikezoe K; Sokai A; Kubo T; Hirai T; Chin K; Togashi K; Mimori T; Mishima M
Mod Rheumatol; 2015 Jul; 25(4):579-84. PubMed ID: 25437196
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study.
Ebbo M; Grados A; Guedj E; Gobert D; Colavolpe C; Zaidan M; Masseau A; Bernard F; Berthelot JM; Morel N; Lifermann F; Palat S; Haroche J; Mariette X; Godeau B; Bernit E; Costedoat-Chalumeau N; Papo T; Hamidou M; Harlé JR; Schleinitz N
Arthritis Care Res (Hoboken); 2014 Jan; 66(1):86-96. PubMed ID: 23836437
[TBL] [Abstract][Full Text] [Related]
8. Role of F-18 FDG PET/CT in assessing IgG4-related disease with inflammation of head and neck glands.
Tokue A; Higuchi T; Arisaka Y; Nakajima T; Tokue H; Tsushima Y
Ann Nucl Med; 2015 Jul; 29(6):499-505. PubMed ID: 25877159
[TBL] [Abstract][Full Text] [Related]
9. Utility of FDG PET/CT in IgG4-related systemic disease.
Nakatani K; Nakamoto Y; Togashi K
Clin Radiol; 2012 Apr; 67(4):297-305. PubMed ID: 22119099
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the quantitative measurement of 18F-FDG PET/CT and histopathological findings in IgG4-related disease.
Tsuji S; Iwamoto N; Horai Y; Fujikawa K; Fujita Y; Fukui S; Ideguchi R; Michitsuji T; Nishihata S; Okamoto M; Tsuji Y; Endo Y; Shimizu T; Sumiyoshi R; Koga T; Kawashiri SY; Igawa T; Ichinose K; Tamai M; Nakamura H; Origuchi T; Kudo T; Kawakami A
Clin Exp Rheumatol; 2021; 39(6):1338-1344. PubMed ID: 33506750
[TBL] [Abstract][Full Text] [Related]
11. Characterization of F-18 Fluorodeoxyglucose PET/CT in Granulomatosis with Polyangiitis.
Nelson DR; Johnson GB; Cartin-Ceba R; Specks U
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Jan; 32(4):342-52. PubMed ID: 26847102
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of
Takano K; Yajima R; Kamekura R; Yamamoto M; Takahashi H; Yama N; Hatakenaka M; Himi T
Laryngoscope; 2018 May; 128(5):1120-1125. PubMed ID: 28988418
[TBL] [Abstract][Full Text] [Related]
13. IgG4-Related Disease Simulating Carcinoma Colon With Diffuse Peritoneal Carcinomatosis on 18F-FDG PET/CT.
Vadi SK; Parihar AS; Kumar R; Singh H; Mittal BR; Bal A; Sinha SK
Clin Nucl Med; 2018 Jul; 43(7):e247-e249. PubMed ID: 29762245
[TBL] [Abstract][Full Text] [Related]
14. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
15. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events.
Figueroa AL; Abdelbaky A; Truong QA; Corsini E; MacNabb MH; Lavender ZR; Lawler MA; Grinspoon SK; Brady TJ; Nasir K; Hoffmann U; Tawakol A
JACC Cardiovasc Imaging; 2013 Dec; 6(12):1250-9. PubMed ID: 24269261
[TBL] [Abstract][Full Text] [Related]
16. Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease?
Signorelli M; Guerra L; Montanelli L; Crivellaro C; Buda A; Dell'Anna T; Picchio M; Milani R; Fruscio R; Messa C
Gynecol Oncol; 2011 Nov; 123(2):236-40. PubMed ID: 21855972
[TBL] [Abstract][Full Text] [Related]
17. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
[TBL] [Abstract][Full Text] [Related]
18. Semiquantitative
An SY; Sun BJ
BMC Cardiovasc Disord; 2024 Feb; 24(1):122. PubMed ID: 38389040
[TBL] [Abstract][Full Text] [Related]
19. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.
Ozkan E; Soydal C; Araz M; Kir KM; Ibis E
Nucl Med Commun; 2012 Apr; 33(4):395-402. PubMed ID: 22367859
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]